Why is this trial important?

Although several clinical trials have addressed the optimal treatment strategy for patients with symptomatic and recurrent AFib, we do not yet have support on the best early treatment plan for those who have just been diagnosed. CHANGE AFib seeks to fill this gap in evidence and determine whether we can better deliver early treatment to help improve long-term outcomes in patients with first-detected AFib.